Type / Class
Equity / American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share
Shares outstanding
9,036,176
Total 13F shares
24,767,928
Share change
-4,718,852
Total reported value
$71,168,352
Price per share
$2.91
Number of holders
48
Value change
-$30,970,776
Number of buys
31
Number of sells
21

Security key

12233L107

Report period

Q2 2022

Institutions

48

Top holders

10

Top shareholders of BNR - Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BAILLIE GIFFORD & CO
13F
Company
99%
8,911,250
$82,786,000 31 Mar 2022
13F
ARK Investment Management LLC
13F
Company
39%
3,516,817
$32,671,000 31 Mar 2022
13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
28%
2,496,493
$23,192,000 31 Mar 2022
13F
Amova Asset Management Americas, Inc.
13F
Company
24%
2,126,513
$19,989,000 31 Mar 2022
13F
Sumitomo Mitsui Trust Group, Inc.
13F
Company
24%
2,126,513
$19,755,000 31 Mar 2022
13F
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC
13F
Company
17%
1,521,308
$14,133,000 31 Mar 2022
13F
ORBIMED ADVISORS LLC
13F
Company
16%
1,452,402
$13,493,000 31 Mar 2022
13F
BlackRock Finance, Inc.
13F
Company
16%
1,436,749
$13,348,000 31 Mar 2022
13F
VANGUARD GROUP INC
13F
Company
12%
1,053,368
$9,786,000 31 Mar 2022
13F
MORGAN STANLEY
13F
Company
9.8%
885,812
$8,230,000 31 Mar 2022
13F
Kynam Capital Management, LP
13F
Company
8.6%
773,114
$7,182,000 31 Mar 2022
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
6%
538,189
$5,000,000 31 Mar 2022
13F
Bellevue Group AG
13F
Company
4.9%
438,869
$4,077,000 31 Mar 2022
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
3.9%
351,360
$3,264,000 31 Mar 2022
13F
NORGES BANK
13F
Company
3.1%
279,963
$2,600,856 31 Mar 2022
13F
HSG Holding Ltd
13F
Company
2.3%
212,121
$1,971,000 31 Mar 2022
13F
BAKER BROS. ADVISORS LP
13F
Company
2.3%
209,131
$1,943,000 31 Mar 2022
13F
STATE STREET CORP
13F
Company
2.2%
196,590
$1,826,000 31 Mar 2022
13F
Bridgewater Associates, LP
13F
Company
1.8%
158,413
$1,472,000 31 Mar 2022
13F
Hudson Bay Capital Management LP
13F
Company
1.5%
133,485
$1,240,000 31 Mar 2022
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
1.3%
113,600
$1,055,000 31 Mar 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.71%
63,829
$592,000 31 Mar 2022
13F
Invesco Ltd.
13F
Company
0.67%
60,609
$563,000 31 Mar 2022
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.65%
58,446
$543,000 31 Mar 2022
13F
Ergoteles LLC
13F
Company
0.58%
52,318
$486,000 31 Mar 2022
13F
Nuveen Asset Management, LLC
13F
Company
0.58%
52,000
$483,000 31 Mar 2022
13F
NATIXIS
13F
Company
0.55%
49,291
$458,000 31 Mar 2022
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.43%
38,907
$374,674 31 Mar 2022
13F
AtonRa Partners
13F
Company
0.41%
36,701
$341,000 31 Mar 2022
13F
TD ASSET MANAGEMENT INC
13F
Company
0.37%
33,593
$312,000 31 Mar 2022
13F
CITADEL ADVISORS LLC
13F
Company
0.32%
28,728
$267,000 31 Mar 2022
13F
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC
13F
Company
0.26%
23,817
$221,000 31 Mar 2022
13F
CITIGROUP INC
13F
Company
0.2%
17,727
$165,000 31 Mar 2022
13F
US BANCORP \DE\
13F
Company
0.17%
15,207
$142,000 31 Mar 2022
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.14%
12,914
$120,000 31 Mar 2022
13F
JANE STREET GROUP, LLC
13F
Company
0.11%
10,390
$97,000 31 Mar 2022
13F
Gyon Technologies Capital Management, LP
13F
Company
0.11%
10,099
$94,000 31 Mar 2022
13F
Legal & General Group Plc
13F
Company
0.06%
5,788
$54,000 31 Mar 2022
13F
UBS Group AG
13F
Company
0.03%
2,498
$23,000 31 Mar 2022
13F
Tower Research Capital LLC (TRC)
13F
Company
0.03%
2,445
$23,000 31 Mar 2022
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.02%
2,245
$21,000 31 Mar 2022
13F
Neil Nanpeng Shen
13F
Individual
0.01%
885
$8,000 31 Mar 2022
13F
PineBridge Investments, L.P.
13F
Company
0%
100
$1,000 31 Mar 2022
13F

Institutional Holders of Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) as of Q2 2022

As of 30 Jun 2022, Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) was held by 48 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,767,928 shares. The largest 10 holders included MASSACHUSETTS FINANCIAL SERVICES CO /MA/, Kynam Capital Management, LP, ARK Investment Management LLC, VANGUARD GROUP INC, BlackRock Inc., ORBIMED ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, CREDIT SUISSE AG/, and BARCLAYS PLC. This page lists 48 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders
43
Q2 2022 holders
48
Holder diff
5
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 Value $ Q2 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .